GI Stool Testing Market 2015-2019 – Global Market Research

胃腸疾患(GI)検便検査の世界市場:便潜血反応検査(FOBT)、臨床微生物学的検便検査

◆タイトル:GI Stool Testing Market 2015-2019 – Global Market Research
◆商品コード:IRTNTR7243
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年9月16日
◆ページ数:61
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、胃腸疾患(GI)検便検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、胃腸疾患(GI)検便検査の世界市場規模及び予測、用途別分析、技術別分析、製品別分析、市場シェア、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

・エグゼクティブサマリー
・市場概観
・業界の構造分析
・胃腸疾患(GI)検便検査の世界市場:市場規模及び予測
・胃腸疾患(GI)検便検査の世界市場:技術別分析
・胃腸疾患(GI)検便検査の世界市場:製品別分析
・胃腸疾患(GI)検便検査の世界市場:用途別分析
・胃腸疾患(GI)検便検査の世界市場:地域別分析
・市場シェア
・市場の成長要因
・市場の課題
・市場動向
・競争状況
・主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About GI stool testing
Normal gastrointestinal (GI) functioning is essential for digestion as well as for the removal of body waste and pathogens. GI disorders are a common problem in the general population. These disorders are known to cause severe harm to the health and quality of life of an individual. These disorders include malabsorption disorders, inflammatory bowel diseases, cancer of the digestive system, colitis, and gastroenteritis. Globally, about 1.7-2 billion cases of diarrheal diseases occur every year. Also, about 1,700 million cases of C. difficile infections have been reported worldwide every year.

Stool tests are used for the diagnosis of GI disorders and help detect parasite infection, inflammation, bleeding obstruction, and tumors in the GI tract and digestive system. The diagnosis of GI diseases is commonly done through laboratory tests using antigen or culture detection from stool samples. A stool test is of two categories: fecal occult blood test (FOBT) and clinical microbiological stool tests. These tests are either antibody-based or microbial particle-based detection methods, which include immunoassay, CLIA, and molecular diagnostic testing. Stool tests are used for the screening of colorectal cancer as well as the detection of pathogens such as C. difficile, H. pylora, Rotavirus, and Adenovirus.

The global GI stool testing market is expected to grow at a CAGR of 7.37% during 2014-2019.

[Covered in this report]
In this report, Technavio covers the present scenario and growth prospects of the global GI stool testing market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of the following products:
• FOBT
• Clinical microbiology stool test

Technavio’s report, Global GI Stool Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global BI and analytics platform market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key regions]
• Americas
• APAC
• EMEA

[Key vendors]
• Clinical Genomics
• Diasorin
• Meridian Bioscience
• Quidel

[Other prominent vendors]
• Alere
• Beckman Coulter
• bioMérieux
• Bio-Rad Laboratories
• CARE Products
• Cenogenics
• EIKEN CHEMICAL
• Epigenomics
• Epitope Diagnostic
• Exact Sciences
• Helena Laboratories
• Hemosure
• Mobidiag
• Orion Diagnostica
• Pinnacle BioLabs
• Polymedco
• Propper Manufacturing
• ScheBo Biotech
• Trinity Biotech

[Market Driver]
• Increased incidence of C. difficile infections
• For a full, detailed list, view our report

[Market challenge]
• Accurate diagnostic testing
• For a full, detailed list, view our report

[Market trend]
• Focus on rapid and early diagnosis
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Reimbursement and coverage: An overview
Current scenario: Validating diagnostic tests
Reimbursement structure in the US
Reimbursement structure in EU
Prevailing issues of reimbursement policies

PART 07: Gastrointestinal stool tests: Present and future technology

PART 08: Market segmentation by product
Reagents
Instruments

PART 09: Market segmentation by application
Colorectal cancer
Diarrhea
Gastrointestinal tract infections
Others

PART 10: Market segmentation by technology

PART 11: Market segmentation by test

PART 12: Geographical segmentation
Global gastrointestinal stool testing market segmentation by geography
Gastrointestinal stool testing market in Americas
Gastrointestinal stool testing market in EMEA
Gastrointestinal stool testing market in APAC

PART 13: Market drivers
Increased incidence of Clostridium difficile infections
Automation and system integration
Early diagnosis of colorectal cancer
Focus on emerging countries

PART 14: Impact of drivers

PART 15: Market challenges
Accurate diagnostic testing
Business and regulatory issues
Alternatives to stool tests

PART 16: Impact of drivers and challenges

PART 17: Market trends
Rapid and early diagnosis
Use of point-of-care tests
Increase in public awareness

PART 18: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 19: Key vendor analysis
Clinical Genomics
DiaSorin
Meridian Bioscience
Quidel

PART 20: Appendix
List of abbreviations

PART 21: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global gastrointestinal stool testing market ($ millions)
Exhibit 03: Reimbursement perspectives of healthcare entities
Exhibit 04: Global gastrointestinal stool testing market segmentation by product
Exhibit 05: Global gastrointestinal stool testing market segmentation by product 2014
Exhibit 06: Global gastrointestinal stool testing market segmentation by application
Exhibit 07: Global gastrointestinal stool testing market segmentation by technology
Exhibit 08: Global gastrointestinal stool testing market segmentation by test
Exhibit 09: Global gastrointestinal stool testing market segmentation by geography 2014
Exhibit 10: Global gastrointestinal stool testing market segmentation by geography 2019
Exhibit 11: Global gastrointestinal stool testing market by geography 2014-2019
Exhibit 12: Gastrointestinal stool testing market in Americas ($ millions)
Exhibit 13: Gastrointestinal stool testing market in EMEA ($ millions)
Exhibit 14: Gastrointestinal stool testing market in APAC ($ millions)
Exhibit 15: Healthcare spending by country 2015 ($ billions)
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: Clinical Genomics: Key takeaways
Exhibit 19: DiaSorin: Key takeaways
Exhibit 20: Meridian Bioscience: Key takeaways
Exhibit 21: Quidel: Key takeaways
Exhibit 22: Clinical Genomics: Product categories
Exhibit 23: DiaSorin: Business segmentation by revenue 2014
Exhibit 24: DiaSorin: Business segmentation by revenue 2013 and 2014
Exhibit 25: DiaSorin: Geographical segmentation by revenue 2014
Exhibit 26: Meridian Bioscience: Business segmentation by revenue 2014
Exhibit 27: Meridian Bioscience: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 28: Meridian Bioscience: Geographical segmentation by revenue 2014
Exhibit 29: Quidel: Product segmentation by revenue 2014
Exhibit 30: Quidel: Product segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 31: Quidel: Geographical segmentation by revenue 2014



【掲載企業】

Quidel Corporation, Meridian Bioscience, Diasorin, Clinical Genomics, Alere, Beckman Coulter, bioMérieux, Bio-Rad Laboratories, CARE Products, Cenogenics, Exact Sciences, Epitope Diagnostic, Epigenomics, EIKEN CHEMICAL, Helena Laboratories, Hemosure, Mobidiag, Orion Diagnostica, Pinnacle BioLabs, Polymedco, Propper Manufacturing, ScheBo Biotech, Trinity Biotech

【資料のキーワード】

検便検査、胃腸疾患、GI検査、便潜血反応検査(FOBT)、臨床微生物学的検便検査、大腸癌、下痢、消化管感染症、検便検査、検便検査試薬、検便検査機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[胃腸疾患(GI)検便検査の世界市場:便潜血反応検査(FOBT)、臨床微生物学的検便検査]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆